Related Experiment Video
Updated: Oct 3, 2025

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Whole-Exome Sequencing Implicates Neuronal Calcium Channel with Familial Atrial Fibrillation
Oliver Bundgaard Vad1,2, Yannan Yan1, Federico Denti1
1Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Insights
Researchers identified a rare genetic variant in CACNA1A linked to atrial fibrillation (AF) in a family study. This loss-of-function variant suggests a novel connection between neuronal ion channel dysfunction and AF risk.
Area of Science:
- Cardiology
- Genetics
- Neuroscience
Background:
- Atrial fibrillation (AF) is a common cardiac arrhythmia with complex, poorly understood causes.
- Limited effective treatments exist due to the heterogeneous and complex pathogenesis of AF.
- Familial AF provides a valuable model for identifying genetic underpinnings of the condition.
Purpose of the Study:
- To identify rare genetic variants associated with atrial fibrillation (AF) in individuals with a family history of the condition.
- To investigate the functional consequences of identified genetic variants.
- To explore novel molecular mechanisms contributing to AF pathogenesis.
Main Methods:
- Whole exome sequencing was performed on a large family cohort exhibiting familial AF.
- Genetic variant segregation analysis was conducted to confirm co-occurrence with AF within the family.
- Functional characterization of the identified variant (CaV2.1-V1686M) was performed using patch-clamp electrophysiology.
Main Results:
- A rare variant, c.5053G > A, in the CACNA1A gene was identified and co-segregated with AF in the studied family.
- The CACNA1A gene encodes the CaV2.1 protein, known for its role in neuronal function.
- Functional analysis revealed that the CaV2.1-V1686M variant exhibits a modest loss-of-function.
Conclusions:
- A rare loss-of-function variant in CACNA1A, a gene primarily associated with neuronal function, is linked to atrial fibrillation.
- This finding suggests a previously unrecognized association between the dysfunction of neuronal ion channels and an increased susceptibility to developing AF.
- The study opens new avenues for understanding AF pathogenesis and potential therapeutic targets by linking cardiac arrhythmia to neuronal ion channel biology.
Abstract:
Background: Atrial Fibrillation (AF) is the most prevalent sustained cardiac arrhythmia, responsible for considerable morbidity and mortality. The heterogenic and complex pathogenesis of AF remains poorly understood, which contributes to the current limitation in effective treatments. We aimed to identify rare genetic variants associated with AF in patients with familial AF. Methods and results: We performed whole exome sequencing in a large family with familial AF and identified a rare variant in the gene CACNA1A c.5053G > A which co-segregated with AF. The gene encodes for the protein variants CaV2.1-V1686M, and is important in neuronal function. Functional characterization of the CACNA1A, using patch-clamp recordings on transiently transfected mammalian cells, revealed a modest loss-of-function of CaV2.1-V1686M. Conclusion: We identified a rare loss-of-function variant associated with AF in a gene previously linked with neuronal function. The results allude to a novel link between dysfunction of an ion channel previously associated with neuronal functions and increased risk of developing AF.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Mechanism of Cardiac Arrhythmias
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

